Perrigo Q4 adj EPS $0.93 (+8.1% YoY); FY 2024 adj EPS $2.57 at guidance midpoint

PERRIGO Co plc

2024-FY EPS reported -$1.25 revenue$4,373,400,000

Q4 net sales $1.14B (-1.6% YoY); organic growth +0.7% despite lost distribution and later cold season.
Q4 adj operating income $194M (+16%); adj operating margin 260 bps expansion to 17.0% due to Project Energize.
Infant formula net sales +17% in Q4; store brand share exited 2024 at high; FDA Wisconsin facility reclassified to No Action Indicated.
FY 2024 operating cash flow $363M (103% conversion); fully repaid $400M 3.9% Senior Notes due Dec 2024.
Project Energize achieved $139M gross annual savings in 2024; target $140-170M by 2026; $95M restructuring charges incurred.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.